Myomo (MYO) Total Liabilities (2016 - 2025)
Myomo (MYO) posted Total Liabilities of $27.2 million for Q4 2025, up 40.0% on a QoQ basis from $19.5 million in Q3 2025, and up 55.35% year-over-year from $17.5 million in Q4 2024.
Myomo (MYO) Total Liabilities (2016 - 2025) Analysis & Trends
Myomo's Total Liabilities history runs 10 years deep, the most recent figure standing at $27.2 million for Q4 2025.
- Quarterly Total Liabilities rose 55.35% year-over-year to $27.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $27.2 million (up 55.35% YoY) and the FY2025 annual result came in at $27.2 million, up 55.35% from the prior year.
- Total Liabilities was $27.2 million for Q4 2025 at Myomo, up from $19.5 million in the prior quarter.
- Across five years, Total Liabilities topped out at $27.2 million in Q4 2025 and bottomed at $3.8 million in Q4 2022.
- A 5-year average of $9.0 million and a median of $5.3 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities dropped 19.64% — and 2025, when it surged 241.22%.
- Myomo's Total Liabilities stood at $4.7 million in 2021, then retreated by 18.86% to $3.8 million in 2022, then surged by 47.06% to $5.6 million in 2023, then surged by 213.47% to $17.5 million in 2024, then jumped by 55.35% to $27.2 million in 2025.
- Business Quant data shows MYO's Total Liabilities at $27.2 million in Q4 2025, $19.5 million in Q3 2025, and $21.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.31 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.99 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.68 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 18.55 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.17 Bn |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | 27.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.23 Mn |
| Sep 30, 2025 | 19.45 Mn |
| Jun 30, 2025 | 21.06 Mn |
| Mar 31, 2025 | 19.18 Mn |
| Dec 31, 2024 | 17.53 Mn |
| Sep 30, 2024 | 7.02 Mn |
| Jun 30, 2024 | 6.51 Mn |
| Mar 31, 2024 | 5.62 Mn |
| Dec 31, 2023 | 5.59 Mn |
| Sep 30, 2023 | 6.03 Mn |
| Jun 30, 2023 | 4.48 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 3.80 Mn |
| Sep 30, 2022 | 4.34 Mn |
| Jun 30, 2022 | 4.21 Mn |
| Mar 31, 2022 | 5.11 Mn |
| Dec 31, 2021 | 4.69 Mn |
| Sep 30, 2021 | 4.31 Mn |
| Jun 30, 2021 | 3.90 Mn |
| Mar 31, 2021 | 4.86 Mn |